Wittington Ventures Closes $180M CAD Fund III

TL;DR

Wittington Ventures, the Toronto-based investment arm tied to the Weston family (the retail dynasty behind Loblaw, Shoppers Drug Mart and formerly Selfridges), has closed its third venture fund at $180 million CAD, a 50% step-up from its $120 million CAD second fund raised in 2022. The vehicle backs Series A and B companies in commerce, consumer, healthcare, climate and food technology, typically writing checks around $10 million, and it leans hard on access to the Weston family's retail and real estate empire as its differentiator. In a Canadian venture market that has spent two years starved of large domestic check-writers, a family office re-upping at scale and increasing fund size is notable on its own merits — and worth watching for what it signals about patient, non-institutional capital filling a gap that traditional LPs have been reluctant to fund.

Key Takeaways

The step-up is real, and it's happening in a tough fundraising climate. Going from $120 million to $180 million CAD is a 50% increase at a moment when many Canadian and US venture firms are struggling to hold fund sizes flat, let alone grow them. That Wittington didn't need to run a traditional LP roadshow to get there says as much about the durability of family-office capital as it does about the firm's own performance.

Strategic LPs are becoming a bigger part of the Canadian venture stack. Wittington's edge isn't just capital — it's the ability to hand a portfolio company a warm intro to Loblaw category buyers, Shoppers Drug Mart shelf space, or PC Financial distribution. That kind of access is difficult for a generalist fund to replicate and gives Wittington a genuine wedge in competitive consumer and healthcare rounds.

Continuity at the top matters more than most funds admit. Jim Orlando, who came over from OMERS Ventures to build this platform, has now raised and deployed across three fund vintages without a strategy pivot. In a market where GP turnover routinely resets a firm's thesis and LP relationships, that kind of consistency is underrated.

Consumer and retail-tech investing is quietly re-heating. After several years where enterprise AI sucked up most of the venture narrative, a fund built specifically around consumer, commerce and food technology closing bigger — not smaller — is a data point that founders building outside pure B2B SaaS and infrastructure should not ignore.

Fund Overview

Fund Name: Wittington Ventures Fund III
Fund Size: $180 million CAD
Stage: Series A and B, with a broader platform that also runs earlier-stage and growth-equity strategies
Check Size: Reportedly around $10 million per company on average
Geography: Canada-based (Toronto headquarters), with a portfolio that includes both Canadian and U.S. companies
Focus: Commerce, consumer, healthcare, climate and food technology
Key LPs: Primarily Wittington Investments, the Weston family's private holding company; additional institutional backers have not been disclosed publicly

Why This Fund Matters

Canadian venture capital has a chronic scale problem: too few domestic funds can write meaningful checks into Series A and B rounds without immediately looking south for a US lead. Wittington closing at $180 million CAD doesn't fix that on its own, but it does add real firepower to a pool of domestic growth-stage capital that has been thin for years. A fund that can lead or anchor a $10 million round without syndicating three other Canadian funds together to get there is structurally useful to the ecosystem, independent of whatever else Wittington brings to the table.

The timing is also worth sitting with. This raise comes not long after the Weston family's roughly $6.9 billion sale of Selfridges, which by all public reporting freed up capital and prompted a broader rethink of how the family deploys money outside its core retail holdings. Venture is getting a bigger allocation inside that rethink, and a fund of this size suggests the family intends to keep scaling its direct venture exposure rather than treating Wittington as a side project or a philanthropic-adjacent experiment.

What separates Wittington from a generic family-office vehicle is the operating access it can offer. Loblaw, Shoppers Drug Mart, President's Choice, Joe Fresh, PC Financial, Choice Properties, Holt Renfrew and PC Optimum are not portfolio companies — they're a distribution and retail network that Wittington's founders can plug portfolio companies into. For a healthcare startup that needs a pharmacy partner or a consumer brand that needs shelf space, that's a value-add most Series A and B investors simply cannot offer, and it's the clearest strategic rationale for why founders should take a Wittington check over a purely financial one at a similar valuation.

The risk sitting underneath all of this is concentration. A fund whose primary LP is also the strategic partner behind its differentiated access is elegant when the family's retail business is healthy and less elegant if Loblaw or its sister businesses hit a rough patch. So far there's no public sign of that, and the fund's own growing size argues against it, but it's the structural question any GP or LP evaluating Wittington's model should keep asking.

The Team

Wittington Ventures is led by two Managing Partners. Jim Orlando runs the climate, commerce and consumer practice; before joining Wittington he was Managing Partner at OMERS Ventures, where he is credited with investments including Shopify, Jobber, Wattpad and DuckDuckGo, and earlier in his career he worked at OMERS Private Equity, Battery Ventures and Bell Canada Ventures. Megh Gupta leads the healthcare and AI-applications practice; he previously served as Global Head of Strategy and Corporate Development at Element AI, where he helped lead a $150 million Series B, and he also spent time investing at OMERS Ventures on deals including Shopify and Wattpad. Both hold current board seats across Wittington's active portfolio.

Below the two Managing Partners, Wittington's current investment team, per the firm's own site, includes Partners Qasim Mohammad (commerce and consumer), Zeeshan Ali (climate and healthcare) and Jodi Kessler (consumer), alongside a bench of directors, senior associates and associates covering the firm's five sector verticals. BetaKit has reported the broader Wittington platform — spanning its venture funds, an early-stage deep-tech strategy and a growth-equity arm — runs roughly 15 people and around $820 million CAD in total assets under management; we're flagging that AUM figure as publicly reported rather than firm-confirmed, since it isn't broken out on Wittington's own site.

Early Portfolio

Wittington's published portfolio spans healthcare AI, autonomous logistics, developer tooling and consumer brands, and includes Abridge, Unlearn, Thirty Madison, Gatik, Contentful, Brave, Arcaea, Truvian, Lemme, Odaia and Noetik, among others — all listed on the firm's own portfolio page. BetaKit's reporting on the Fund III close also names Grey Matter Neurosciences, Shakudo and ViewsML as more recent additions, alongside a target of roughly 15 new portfolio companies to be added from this fund; we're labeling those newer names as publicly reported pending confirmation on Wittington's own portfolio page.

What This Means for Founders

Founders building at Series A or B in commerce, consumer products, healthcare, climate or food technology — particularly those who could use a foot in the door with a major Canadian retailer, pharmacy chain or financial-services brand — are the clearest fit here. This is not a fund for pure infrastructure or horizontal enterprise SaaS plays with no obvious retail or consumer tie-in; Wittington's own positioning is built around sectors where its family-office relationships actually move the needle for a portfolio company.

The value-add pitch is fundamentally different from a typical institutional VC's operating-support playbook. Instead of a recruiting team and a Slack community of portfolio founders, Wittington is selling access to real commercial relationships inside one of Canada's largest retail and pharmacy networks. Founders should go in with a clear-eyed pilot or partnership ask in mind — the firm's leverage is strongest when there's a concrete Loblaw, Shoppers or PC Financial connection to make, not as a generic warm-intro machine.

Fund Momentum Take

We like this close more for what it says about the state of Canadian growth-stage capital than for anything unique about Wittington's strategy, which is a fairly conventional sector-focused Series A/B fund dressed up with a genuinely uncommon LP. A family office that keeps scaling its venture allocation through three fund vintages, without a public GP shakeup or strategy drift, is a rarer thing in this market than it should be, and founders in Wittington's sectors would be wrong to write it off as a lifestyle vehicle just because it doesn't run a traditional LP process.

Our biggest question is durability beyond the Orlando-Gupta partnership. Wittington's edge is inseparable from its access to Weston-family retail assets, and its investment thesis is inseparable from Jim Orlando's OMERS-era relationships and reputation. That's a strength today and a single point of failure over a ten-year fund life if either leadership pillar changes. We'd also flag that the firm has not disclosed outside institutional LPs, which keeps it nimble but also means its scale ambitions are ultimately capped by how much the Weston family itself wants to commit to venture as an asset class.

Our bet: Wittington becomes one of the more consistently active Series A/B checks in Canadian consumer, healthcare and climate deals over the next two to three years, precisely because it isn't racing to raise a fourth fund off someone else's LP calendar. The retail-access thesis is real, the team has stayed intact, and the step-up from Fund II to Fund III suggests the family sees compounding returns worth reinvesting rather than harvesting. The thing to watch is whether Wittington ever opens up to outside institutional capital — that would be the clearest signal the strategy is working well enough to scale beyond one family's balance sheet.

Frequently Asked Questions

How big is Wittington Ventures' new fund?
Wittington Ventures closed its third fund, Fund III, at $180 million CAD, announced around September 10, 2026.

How does Fund III compare to Wittington's previous fund?
Fund III is roughly 50% larger than Wittington Ventures' second fund, which closed at $120 million CAD in 2022, according to BetaKit's reporting.

Who are Wittington Ventures' Managing Partners?
Jim Orlando (climate, commerce and consumer, formerly Managing Partner at OMERS Ventures) and Megh Gupta (healthcare and AI, formerly of Element AI) are Wittington Ventures' current Managing Partners, per the firm's own team page.

What stages and sectors does Wittington Ventures invest in?
The firm focuses on Series A and B companies in commerce, consumer, healthcare, climate and food technology, with average checks reportedly around $10 million.

Who backs Wittington Ventures?
Wittington Ventures is primarily backed by Wittington Investments, the private holding company of the Weston family, the Canadian retail dynasty behind Loblaw, Shoppers Drug Mart and other consumer brands. Additional institutional LPs have not been publicly disclosed.

---

Have a fund closing to announce? Submit your fund here.

Need help raising capital? Check out our Fundraising Advisory services.